Hematogenous dissemination of glioblastoma multiforme
Standard
Hematogenous dissemination of glioblastoma multiforme. / Müller, Carolin; Holtschmidt, Johannes; Auer, Martina; Heitzer, Ellen; Lamszus, Katrin; Schulte, Alexander; Matschke, Jakob; Langer-Freitag, Sabine; Gasch, Christin; Stoupiec, Malgorzata; Mauermann, Oliver; Peine, Sven; Glatzel, Markus; Speicher, Michael R; Geigl, Jochen B; Westphal, Manfred; Pantel, Klaus; Riethdorf, Sabine.
In: SCI TRANSL MED, Vol. 6, No. 247, 30.07.2014, p. 247ra101.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Hematogenous dissemination of glioblastoma multiforme
AU - Müller, Carolin
AU - Holtschmidt, Johannes
AU - Auer, Martina
AU - Heitzer, Ellen
AU - Lamszus, Katrin
AU - Schulte, Alexander
AU - Matschke, Jakob
AU - Langer-Freitag, Sabine
AU - Gasch, Christin
AU - Stoupiec, Malgorzata
AU - Mauermann, Oliver
AU - Peine, Sven
AU - Glatzel, Markus
AU - Speicher, Michael R
AU - Geigl, Jochen B
AU - Westphal, Manfred
AU - Pantel, Klaus
AU - Riethdorf, Sabine
N1 - Copyright © 2014, American Association for the Advancement of Science.
PY - 2014/7/30
Y1 - 2014/7/30
N2 - Glioblastoma multiforme (GBM) is the most frequent and aggressive brain tumor in adults. The dogma that GBM spread is restricted to the brain was challenged by reports on extracranial metastases after organ transplantation from GBM donors. We identified circulating tumor cells (CTCs) in peripheral blood (PB) from 29 of 141 (20.6%) GBM patients by immunostaining of enriched mononuclear cells with antibodies directed against glial fibrillary acidic protein (GFAP). Tumor cell spread was not significantly enhanced by surgical intervention. The tumor nature of GFAP-positive cells was supported by the absence of those cells in healthy volunteers and the presence of tumor-specific aberrations such as EGFR gene amplification and gains and losses in genomic regions of chromosomes 7 and 10. Release of CTCs was associated with EGFR gene amplification, suggesting a growth potential of these cells. We demonstrate that hematogenous GBM spread is an intrinsic feature of GBM biology.
AB - Glioblastoma multiforme (GBM) is the most frequent and aggressive brain tumor in adults. The dogma that GBM spread is restricted to the brain was challenged by reports on extracranial metastases after organ transplantation from GBM donors. We identified circulating tumor cells (CTCs) in peripheral blood (PB) from 29 of 141 (20.6%) GBM patients by immunostaining of enriched mononuclear cells with antibodies directed against glial fibrillary acidic protein (GFAP). Tumor cell spread was not significantly enhanced by surgical intervention. The tumor nature of GFAP-positive cells was supported by the absence of those cells in healthy volunteers and the presence of tumor-specific aberrations such as EGFR gene amplification and gains and losses in genomic regions of chromosomes 7 and 10. Release of CTCs was associated with EGFR gene amplification, suggesting a growth potential of these cells. We demonstrate that hematogenous GBM spread is an intrinsic feature of GBM biology.
U2 - 10.1126/scitranslmed.3009095
DO - 10.1126/scitranslmed.3009095
M3 - SCORING: Journal article
C2 - 25080476
VL - 6
SP - 247ra101
JO - SCI TRANSL MED
JF - SCI TRANSL MED
SN - 1946-6234
IS - 247
ER -